Navigation Links
Hologic Expands Healthcare Investment in Asia
Date:10/19/2009

BEDFORD, Mass., Oct. 19 /PRNewswire-FirstCall/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the opening of its new Asia Pacific regional offices and the Hologic Asia Pacific Center for Health Sciences Education in Hong Kong. Sales, product support, training, R&D, logistics, health sciences education, and service for Hologic's breast health, diagnostics, GYN surgical, and skeletal health businesses for the Asia Pacific market will be coordinated from the new facility. Company officials joined country and local leaders, customers and medical luminaries for an opening ceremony at the new facility dedication in the Hong Kong Science Park.

Commenting on the new facility, Jack Cumming, Hologic chairman and chief executive officer said, "This new regional headquarters is another step in our drive to leverage complementary, best-in-class products and technologies to better meet local market needs while driving enhanced growth and value creation for Hologic, our dealers and their customers. With this new facility, we can now offer, in one location, training and educational programs for doctors, radiologists, cytologists, technologists, and application and service support personnel for all our product lines. The investment in Asia is another positive step in Hologic's strategic initiative to expand its international footprint with future plans for regional centers in India and South America."

Paul Young, managing director of Hologic's Asia Pacific region noted, "The Hong Kong facility is complementary to similar Hologic facilities in Boston, Massachusetts, Brussels, Belgium, and London, U.K., and another important step in the process of building regional centers to better serve local needs in all regions of the world."

"The dedication of the sales, service and support associates of Hologic is a key reason for the Company's success," Mr. Cumming noted. "The associates working from the new Hong Kong headquarters are part of a network of more than 4,000 Hologic team members who have come together to redefine what is possible. They work on healthcare initiatives that save lives. Their shared goal is to have each Hologic product be best in class, offering more health, more life, and more hope for more women."

The address of the new facility is:

Hologic Asia Pacific Limited

7th Floor, Biotech Centre 2

No. 11 Science Park West Avenue

Hong Kong Science Park

Shatin, New Territories, HONG KONG

About Hologic

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications.

Forward Looking Statement Disclaimer

This News Release contains forward looking information that involves risks and uncertainties, including statements about Hologic's plans, objectives, expectations and intentions. Such statements include, without limitation, statements regarding the expected benefits of its new Asia Pacific headquarters facility. These forward looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to the data or statements presented herein to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such data or statements are based. Certain factors that could adversely affect the Company's business and prospects are described in Hologic filings with the Securities and Exchange Commission.

    Contacts: James Culley, Ph.D.       SK Tse (Siu-Kai Tse)
              Corporate Marketing       HK Managing Director, Far East Sales
              Hologic, Inc.             Hologic Asia Pacific Limited
              Boston, Mass. USA         Hong Kong, China
              +1(302) 528-1312          +(852) 3748 7700
              jim.culley@hologic.com    siu-kai.tse@hologic.com

SOURCE Hologic, Inc.


'/>"/>
SOURCE Hologic, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
2. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
3. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
4. Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer
5. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
6. ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrigs Disease
7. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
8. NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
9. Raptor Pharmaceutical Expands Board of Directors
10. Intermountain McKay-Dee Hospital Center Expands Real-Time Locating Solution From Versus Technology, Inc.
11. Lupin Expands Branded Play
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Md. , Feb. 27, 2017  RegeneRx ... a clinical-stage drug development company focused on tissue ... licensee for RGN-137, GtreeBNT Co., Ltd., received a ... Phase 3 clinical trial design for RGN-137 to ... wound healing gel that incorporates Thymosin beta 4 ...
(Date:2/27/2017)... 27, 2017 A recent research report published ... market alone is expected to reach a value of $55.8 billion ... along with 28 states have legalized marijuana for medical uses. In ... Florida , North Dakota , ... to use the drug in medical applications such as chemotherapies and ...
(Date:2/27/2017)... N.J. and PETACH TIKVAH, Israel ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... appointments of June S. Almenoff , M.D., Ph.D., ... to its Board of Directors.  "Dr. ... executives whose appointments come at an exciting time for ...
Breaking Medicine Technology:
(Date:2/27/2017)... , ... February 27, 2017 , ... The threat of ... to work for a company involved in the underground testing of nuclear weapons. Years ... for Answers: Expendable Workers of the Cold War Nuclear Testing,” Clayton exposes the critical ...
(Date:2/27/2017)... ... 2017 , ... Orange County dentist, Dr. A. Rassouli, comments on ... when the bacteria in plaque infect the gums and other tissues supporting the teeth. ... planing or SRP, and can include surgical therapies if the condition has led to ...
(Date:2/27/2017)... ... February 26, 2017 , ... Miro is the ultimate smart media ... system brings songs, movies, TV shows and much more apps for user exploration. Its ... An immersive view of 1280 x 720 provides crisp images with remarkable clarity and ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... threshold mark last week. In addition, Discount Power's RCE (Residential Customer Equivalent) count ... in March 2014. The company had 800 customers and 2,250 RCEs at the ...
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... for hair transplantation therapy, is proud to announce a new informational post on ... therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation (FUT) ...
Breaking Medicine News(10 mins):